Colecalciferol/Risedronate Sodium

胆骨化醇/利塞膦酸钠

Report date: 2026/02/05 15:08:40

Base Information

Drug NameColecalciferol/Risedronate Sodium
Drug Alias Name利塞膦酸钠和胆骨化醇Risedronate Sodium Hydrate/Colecalciferol利塞膦酸钠-胆骨化醇Risedronate Sodium Hydrate-ColecalciferolRisedronate Sodium and Colecalciferol +[16
ClassificationSmall molecules
Mechanisms of ActionVitamin D receptor agonistsFarnesyl diphosphate synthase inhibitors
TargetsVitamin D receptorFarnesyl diphosphate synthase
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2010/06/01
Country/TerritorySouth KoreaMainland China
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsOsteoporosis, Postmenopausal

Other Information

ATC CodeM05BB
Related LinksN/A